I reserved my first Bluesky post to mark another enjoyable and successful collaboration with the Jabado and Kleinman labs! Congrats to @selinjessa.bsky.social, Bhavyaa and Antonella on this cool paper!
doi.org/10.1158/0008...
doi.org/10.1158/0008...
FOXR2 targets LHX6+/DLX+ neural lineages to drive CNS neuroblastoma
Abstract. Central nervous system neuroblastoma with FOXR2 activation (NB-FOXR2) is a high-grade tumor of the brain hemispheres and a newly identified molecular entity. Tumors express dual neuronal and...
doi.org
November 7, 2024 at 11:17 AM
I reserved my first Bluesky post to mark another enjoyable and successful collaboration with the Jabado and Kleinman labs! Congrats to @selinjessa.bsky.social, Bhavyaa and Antonella on this cool paper!
doi.org/10.1158/0008...
doi.org/10.1158/0008...
Scientists uncovered new insights into FOXR2 activation in pediatric brain tumors, reshaping diagnostic and treatment approaches. FOXR2 was previously thought to occur only in CNS neuroblastoma. Using data from St. Jude Cloud, researchers found it activated in other tumor types. ow.ly/O6Mx50VBPav
Discovery of FOXR2 activation in various brain tumors refines diagnosis to improve care
Read research showing activation of oncogene FOXR2 occurs in multiple pediatric central nervous system tumor types, with implications for clinical diagnosis.
ow.ly
April 16, 2025 at 5:00 PM
Scientists uncovered new insights into FOXR2 activation in pediatric brain tumors, reshaping diagnostic and treatment approaches. FOXR2 was previously thought to occur only in CNS neuroblastoma. Using data from St. Jude Cloud, researchers found it activated in other tumor types. ow.ly/O6Mx50VBPav
New research from St. Jude Children’s Research Hospital extensively analyzed patient data and showed that oncogene FOXR2 is not exclusive to CNS neuroblastoma and can occur in other types of tumors, providing guidance on diagnosis, prognosis and treatment.
www.stjude.org/media-resour...
www.stjude.org/media-resour...
Discovery of FOXR2 activation in various brain tumors refines diagnosis to improve care
Read research showing activation of oncogene FOXR2 occurs in multiple pediatric central nervous system tumor types, with implications for clinical diagnosis.
www.stjude.org
April 30, 2025 at 12:08 PM
New research from St. Jude Children’s Research Hospital extensively analyzed patient data and showed that oncogene FOXR2 is not exclusive to CNS neuroblastoma and can occur in other types of tumors, providing guidance on diagnosis, prognosis and treatment.
www.stjude.org/media-resour...
www.stjude.org/media-resour...
RRID:SCR_021158 was used by the authors of the Cancer Research paper "FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma". RRIDs like this improve reproducibility in scientific research. #ReproducibleResearch #reproducibility
doi.org
February 4, 2025 at 8:01 AM
RRID:SCR_021158 was used by the authors of the Cancer Research paper "FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma". RRIDs like this improve reproducibility in scientific research. #ReproducibleResearch #reproducibility
FOXR2 gene found active in various pediatric brain tumors, not just CNS neuroblastoma. This discovery could revolutionize diagnosis and treatment. #PediatricCancer #FOXR2 #BrainTumorResearch
FOXR2 Gene Rewrites the Map of Pediatric Brain Tumors
St. Jude researchers have discovered that the FOXR2 gene is active in various pediatric brain tumors, not just CNS neuroblastoma, potentially transforming diagnostic and treatment approaches.
geekoo.news
April 21, 2025 at 11:00 AM
FOXR2 gene found active in various pediatric brain tumors, not just CNS neuroblastoma. This discovery could revolutionize diagnosis and treatment. #PediatricCancer #FOXR2 #BrainTumorResearch
Feed: "Latest Science News -- ScienceDaily"
Published on Wednesday, April 16, 2025
Published on Wednesday, April 16, 2025
Discovery of FOXR2 activation in various brain tumors refines diagnosis to improve care
Scientists have implicated the FOXR2 gene in previously unassociated brain tumor types, with implications for diagnosis, prognosis and treatment.
www.sciencedaily.com
April 17, 2025 at 3:52 AM
Feed: "Latest Science News -- ScienceDaily"
Published on Wednesday, April 16, 2025
Published on Wednesday, April 16, 2025